Regulatory Intelligence Reimagined (subscription)

A cutting-edge reference for mastering regulatory intelligence in the age of AI. This 28-chapter guide combines expert insights with real-world stories and practical frameworks.

Table of Contents

Section 1: The Basics

  • Chapter 1: A General Framework for Regulatory Intelligence in Medical Product Research and Development
  • Chapter 2: Paving Your Path in Regulatory Intelligence: Skill Development and Transition Strategies
  • Chapter 3: Establishing a Robust Regulatory Intelligence Function
  • Chapter 4: Scoping Regulatory Intelligence Deliverables
  • Chapter 5: Establishing Key Performance Indicators to Advocate for a Dedicated Regulatory Policy and Intelligence Function
  • Chapter 6: Homegrown Regulatory Intelligence Tools
  • Chapter 7: Regulatory Intelligence Tools

Section 2: Deliverables

  • Chapter 8: Monitoring and Surveillance
  • Chapter 9: FOIA and Access to Information
  • Chapter 10: Partnering With SMEs on Impact Analysis
  • Chapter 11: Regulatory Intelligence Distribution and Communication
  • Chapter 12: What Is Regulatory Research, and Why Is It Important?
  • Chapter 13: Discovering Regulatory Intelligence Within Your Records
  • Chapter 14: Regulatory Intelligence: How to Measure Success
  • Chapter 15: Monitoring, Analyzing, and Interpreting Regulatory Trends

Section 3: Supporting Health Authority Interactions

  • Chapter 16: Creating More Strategic Submissions Through FDA Division and Reviewer Profiling
  • Chapter 17: Creating More Effective Health Authority Meetings Through Participant Profiling
  • Chapter 18: Public Sources of Regulatory Precedent
  • Chapter 19: Applications of Regulatory Precedent Research
  • Chapter 20: Supporting Device Development and Approval Pathway Strategies
  • Chapter 21: Regulatory Intelligence’s Role in Preparing the Due Diligence Team

Section 4: The Policy Side

  • Chapter 22: Introduction to Regulatory Policy
  • Chapter 23: Leveraging Collective Influence in Regulatory Policy: The Value of Engaging With External Stakeholders
  • Chapter 24: Best Practices in Commenting
  • Chapter 25: Development of White Papers

Section 5: The Intersection of Artificial Intelligence and Regulatory Intelligence

  • Chapter 26: Artificial Intelligence and Its Potential in Regulatory Intelligence
  • Chapter 27: Use of Artificial Intelligence/Machine Learning to Enhance Regulatory Intelligence Analysis Capabilities
  • Chapter 28: Embracing the Digital Revolution: Applying AI and ML Technology Within the Regulatory Intelligence Function

Linda Bowen, MS, RAC, FRAPS, editor

Contributing Authors


About the Book

Learn to drive real impact through regulatory intelligence at your organization.

Regulatory Intelligence Reimagined brings together today’s foremost experts to redefine how organizations approach RI. This 28-chapter comprehensive guide is designed to help both new and experienced professionals build, deploy, maintain, and evolve regulatory intelligence functions that drive real strategic impact.

A new approach to regulatory intelligence fully reimagined for today’s regulatory intelligence landscape:

  • AI woven throughout turns data into actionable insights
  • RI leaders share real-world lessons from their experiences
  • Practical guidance to build, sustain, and grow high-performing RI teams
  • Available in searchable e-book format, built for today’s regulatory professional

The book is organized into five sections – The Basics, Deliverables, Supporting Health Authority Interactions, The Policy Side, and The Intersection of Artificial Intelligence and Regulatory Intelligence – to create a clear and intuitive progression of ideas. The structure reflects not only how regulatory intelligence functions in practice, but also how it continues to expand in scope and sophistication.

To bring this framework to life, the book draws on the expertise of a truly diverse group of contributors – professionals actively practicing RI and policy across biopharma, medical devices, contract research organizations, and regulatory intelligence service organizations. Our authors represent companies both small and large, and they bring perspectives shaped by work in the US, UK, and across Europe. Their collective experience forms the backbone of this book.


Meet the Lead Editor

Linda Bowen, MS, RAC, FRAPS, is a distinguished regulatory affairs leader with more than three decades of experience shaping global regulatory strategy, intelligence, and policy. She has held senior roles at Pfizer (Seagen), Sanofi, Bayer, and GSK (Block Drug), where she built and led high performing teams and engaged extensively with health authorities, trade associations, industry consortia, and professional organizations worldwide. Linda has been an Adjunct Professor in Temple University’s RAQA graduate program since 1998. She holds Regulatory Affairs Certifications (RAC) for the US, Canada, and Europe and is a RAPS Fellow.

Her contributions have been recognized through multiple honors, including the RAPS 2020 Founder’s Award, the Drug Information Association’s 2012 Excellence in Volunteer Leadership Award, the 2019 Americas Inspire Award, and the 2022 Global Inspire Award for Community Engagement. She served on the RAPS Board of Directors and has served on the leadership team of the NJ/NY RAPS Chapter since its founding in 2003. She chaired RAPS Convergence in 2018 and 2019, serves on the 2024–2026 RAPS Regulatory Intelligence Conference Committee, and hosts the RAPS Regulatory Intelligence Collaborative Community.


Purchasing Options

This book can be purchased in the following formats:

  • Subscription.* A three-year subscription including the digital e-book version as well as automatic updates whenever a new edition and/or chapters are released during the subscription period.
  • Digital e-book. Single purchase; accessible online via RAPS Library online reader and downloadable.
  • Printed book.

This book can also be purchased as part of the following bundles:

*All subscriptions listed above (excluding the All Access Library) are for three years. They grant you access to the products in the bundle. During this period, you can read the content online or download books as PDFs for offline use. You’ll also receive automatic updates to any new editions of the books and/or chapters included in your subscription. Learn more about subscriptions.


Published by RAPS © 2026. Paperback. 234 pages. ISBN (print): 979-8-9939132-0-9. ISBN (digital): 979-8-9939132-1-6. Library of Congress Control Number: 2026931109.

×

Welcome to the new RAPS Digital Experience

We have completed our migration to a new platform and are pleased to introduce the updated site.

What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.

We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.

We welcome your feedback. Please let us know how we can continue to improve your experience.